Shares of Ventas, Inc. (NYSE:VTR – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen analysts that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $90.4667.
VTR has been the subject of several research reports. Scotiabank raised their target price on Ventas from $80.00 to $93.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. The Goldman Sachs Group reiterated a “buy” rating and issued a $100.00 price target on shares of Ventas in a report on Monday, February 9th. KeyCorp raised their price objective on Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Citigroup boosted their price objective on Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, February 11th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $93.00 target price on shares of Ventas in a report on Monday, February 9th.
Read Our Latest Research Report on Ventas
Insider Buying and Selling at Ventas
Institutional Trading of Ventas
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Cloud Capital Management LLC bought a new position in shares of Ventas in the third quarter valued at approximately $25,000. GoalVest Advisory LLC purchased a new position in shares of Ventas during the fourth quarter valued at approximately $26,000. Wiser Advisor Group LLC bought a new stake in Ventas during the third quarter worth $27,000. True Wealth Design LLC grew its holdings in Ventas by 1,557.7% during the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 405 shares in the last quarter. Finally, IFC & Insurance Marketing Inc. purchased a new stake in Ventas in the 4th quarter valued at $30,000. 94.18% of the stock is owned by institutional investors.
Ventas Stock Up 0.4%
Ventas stock opened at $82.08 on Friday. The company has a market capitalization of $38.99 billion, a PE ratio of 152.00, a PEG ratio of 2.02 and a beta of 0.75. Ventas has a 12-month low of $60.15 and a 12-month high of $88.36. The firm’s fifty day moving average is $83.27 and its 200 day moving average is $77.79. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03.
Ventas (NYSE:VTR – Get Free Report) last posted its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The company had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the previous year, the business posted $0.81 earnings per share. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, sell-side analysts predict that Ventas will post 3.4 EPS for the current fiscal year.
Ventas Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.52 per share. The ex-dividend date is Tuesday, March 31st. This is a positive change from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a yield of 2.5%. Ventas’s dividend payout ratio is currently 385.19%.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Read More
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
